Related Experiment Videos
Molecular targets for modulating lung inflammation and injury
R T Sadikot1, J W Christman, T S Blackwell
1Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2650, USA. ruxana.sadikot@vanderbilt.edu
Current Drug Targets
|July 24, 2004
Summary
New therapies for inflammatory lung diseases target key molecules. Understanding molecular biology advances treatments for conditions like COPD and cystic fibrosis.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Immunology
Background:
- Inflammatory lung diseases, including COPD, cystic fibrosis, and ARDS, are major therapeutic targets.
- Recent advances in molecular biology have significantly improved understanding of inflammatory pathways.
- This knowledge facilitates the development of novel therapeutic interventions and clarifies mechanisms of existing drugs.
Purpose of the Study:
- To review the functions and therapeutic potential of molecular targets for inflammatory lung diseases.
- To identify promising molecules for novel anti-inflammatory therapies.
- To discuss cell surface receptors, transcription factors, and regulatory proteins as potential targets.
Main Methods:
- Literature review of molecular targets in inflammatory lung diseases.
- Analysis of the roles of cell surface proteins/receptors (TLRs, TREMs, syndecans).
- Examination of transcription factors (NF-kappaB, AP-1, PU.1, HMGB1) and regulatory proteins (MIF, GM-CSF, COX-2, HO-1).
Main Results:
- Identified cell surface receptors like TLRs, TREMs, and syndecans as potential therapeutic targets.
- Highlighted transcription factors such as NF-kappaB, AP-1, PU.1, and HMGB1 for their roles in inflammation.
- Discussed regulatory proteins including MIF, GM-CSF, COX-2, and HO-1 with therapeutic implications.
Conclusions:
- Several molecular targets show promise for treating inflammatory lung diseases.
- Targeting these molecules offers new avenues for therapeutic intervention.
- Further research into these targets could lead to improved treatments for patients with lung inflammation.